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Abstract
The surgical mesh material used in the surgical treatment of stress urinary incontinence (SUI) and pelvic organ prolapse 
(POP) in women is associated with signiicant complications in some women. This has recently become a public health 
issue with involvement of national parliaments and regulatory bodies. The occurrence of mesh complications is thought to 
be a result of multifactorial processes involving problems related to the material design, the surgical techniques used and 
disease, and patient-related factors. However, the infectious complications and mesh–tissue interactions are least studied. 
The aim of this article is to review any previous clinical and basic scientiic evidence about the contribution of infectious 
and inlammatory processes to the occurrence of mesh-related complications in SUI and POP. A literature search for the 
relevant publications without any time limits was performed on the Medline database. There is evidence to show that vaginal 
meshes are associated with an unfavourable host response at the site of implantation. The underlying mechanisms leading to 
this type of host response is not completely clear. Mesh contamination with vaginal lora during surgical implantation can 
be a factor modifying the host response if there is a subclinical infection that can trigger a sustained inlammation. More 
basic science research is required to identify the biological mechanisms causing a sustained inlammation at the mesh–tissue 
interface that can then lead to contraction, mesh erosion, and pain.
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Introduction
Surgical mesh, mostly made of polypropylene (PPL), used 
in the surgical treatment of stress urinary incontinence (SUI) 
and pelvic organ prolapse (POP) has become a public health 
problem being frequently quoted as the biggest scandal after 
the thalidomide disaster. Recently, New Zealand became the 
irst country to ban these products for use in transvaginal 
POP repair [1]. In the UK, two parliaments undertook pub-
lic enquiries as a result of immense pressure from patient 
organizations leading to a recent suspension of vaginal mesh 
products for both SUI and POP [2]. On the other hand, the 
British Society of Urogynaecologists expressed strong disa-
greement with the decision stating that many women with 
SUI would be deprived of an efective and safe treatment 
modality as a result of this decision, while they agreed with 
the decision to cease using vaginal mesh for POP [3]. All 
these discussions are being widely covered in the media with 
a lot of public attention.
The success and complication rates for vaginal mesh sur-
geries appear to be highly variable with better risk/beneit 
ratios when used for treatment of SUI as compared to POP. 
This implies that factors related to disease mechanisms, 
surgical techniques, and material properties also have an 
impact on the occurrence of vaginal mesh complications. 
One important factor is probably related to material proper-
ties of the surgical mesh and its suitability when used in the 
pelvic loor. The surgical mesh became available for surgical 
use shortly after the plastics revolution and it was a sig-
niicant advancement in materials science at the time that 
it was introduced [4]. The plastic materials provided sig-
niicant advantages over the metal prosthesis in soft-tissue 
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reconstruction with their ductility and strength. However, 
plastic meshes were not as resistant to infection as the met-
als that necessitated modiications to material properties to 
decrease bacterial attachment and adaptations of the surgical 
technique of hernia repair to prevent long-term colonization 
of the mesh [5].
Mesh-related infections are relatively rare after mesh 
augmented pelvic loor repair procedures; however, when 
they do occur, they can signiicantly compromise patients’ 
well-being and can lead to excision of the mesh implant. 
This year, we sadly learnt from a newspaper article that a 
well-known mesh campaigner died of sepsis attributed to 
recurrent urinary tract infections (UTIs) developed after 
a mid-urethral sling implantation to treat SUI [6]. Mesh-
related complications due to infection have been reported 
to occur in 0–8% of all cases, but generally speaking, they 
appear to be less than 1% in transvaginal mesh implantations 
for the treatment of both SUI and POP [7, 8]. These igures 
relect clinically evident infection with typical systemic ind-
ings (fever, malaise, etc.) and local signs of infection at the 
site of implantation. Mesh infection is also thought to be 
asymptomatic (silent), but it can actually interfere with the 
successful integration of the mesh into host tissues lead-
ing to mesh exposure in some cases [9]. A positive bacte-
rial culture was obtained from 77% of the vaginal meshes 
explanted due to pain, mesh erosion, mesh infection, and 
recurrent UTIs [10]. Therefore, mesh-related infections can 
be a solitary complication of vaginal mesh surgeries, and at 
the same time, it can be one of the factors in a multifactorial 
process underlying other mesh-related complications such 
as exposure and pain.
Infectious complications have also been a major issue 
for other polymer-based biomedical implants designed for 
soft-tissue replacement/augmentation such as the breast 
implants. The relationship between the biomaterial infection 
and implant-related complications is relatively well studied 
in this context. For implant-based breast augmentation sur-
geries, capsular contraction is known to be a major cause 
of reoperation [11]. Theories on the occurrence of capsular 
contraction are hypertrophic scar, myoibroblast activation, 
silicone gel leak, haematoma, and infection. The latter sug-
gests that a microbial colonization of the implant causes 
a persistent low-grade infection leading to what is called 
a subclinical infection and capsular contraction. Breast 
implants explanted for capsular contracture revealed a 41% 
culture positivity for microorganisms which were mainly 
skin lora [12]. Although this theory could explain some 
of these clinical complications, clinical relevance is limited 
due to lack of non-invasive methods that can provide such 
evidence.
The aim of this article is to review available clinical and 
basic scientiic evidence about infection complications of 
vaginal mesh surgeries. We irst investigated the speciic 
tissue reactions to the implanted vaginal meshes. We then 
considered vaginal mesh colonization and infection as mech-
anisms to explain mesh-related complications in urogyneco-
logical surgery.
Methods
A Medline search was conducted on October 2018 using 
the following as subject headings, keywords, and text 
words: (stress urinary incontinence OR pelvic organ 
prolapse) AND (surgical mesh OR polypropylene) AND 
(infection OR wound infection OR post-operative compli-
cations OR intraoperative complications). No time limits 
were applied to the search. A total of 168 abstracts were 
retrieved. All relevant articles were included. In addition, 
reference lists of selected manuscripts were checked man-
ually for eligible articles.
Infectious complications of vaginal mesh surgeries 
in clinical practice
Vaginal mesh is used in urogyneacological surgeries 
mainly to treat SUI and POP. It is used in the female pelvic 
loor in three main ways: transvaginal treatment for SUI, 
transabdominal repair of POP, and transvaginal repair of 
POP.
For transabdominal implantations, namely, abdomi-
nal sacrocolpo(histero)pexy operations, the mesh mate-
rial is used to attach the apex of the vagina or uterus to 
the sacrum, replacing defective or weak cardinal-utero-
sacral ligaments constituting level I support structures 
[13]. These ligaments are thick and strong collagenous 
ibres extending both vertically and posteriorly towards 
the sacrum, meaning that it is not necessarily lexible, 
but strong in the vertical direction which matches with 
the mechanical properties of the surgical mesh. In addi-
tion, in these operations, the mesh does not traverse a 
clean contaminated surgical ield and it does not lie in 
close proximation to skin. Thus, the mesh in abdominal 
implantations is biomechanically more it for purpose for 
this application and the chances of contamination during 
implantation is less compared to vaginal implantations. 
The success of transabdominal repairs is very good at 
97–100% [14], although mesh erosion still occurring in 
up to 6% by 2 years [15] and 10% in 7 year follow-up 
[16]. Mesh infection rates are also thought to occur less in 
abdominal POP repairs compared to vaginal POP repairs, 
since the irst approach avoids contamination of the mesh 
during insertion [17]. Furthermore, avoiding a hysterec-
tomy during abdominal sacrocolpopexies is recommended 
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to reduce likelihood of mesh complications by preventing 
the contact of the mesh with vaginal microbial lora.
In transvaginal POP repair procedures, the vaginal sup-
port structures, mainly at level II, are attached to stronger 
ligaments in the pelvic loor (e.g., sacrospinous or utero-
sacral ligaments) or are augmented with a suture repair in 
pubocervical or rectovaginal fascia (anterior and poste-
rior colporrhaphy procedures). This fascia is mainly com-
posed of smooth muscle and collagen/elastin, which are 
the active biomechanical components of the pelvic loor 
that are probably subjected to not well-deined multidi-
mensional forces. More importantly, during these opera-
tions, the mesh traverses a clean contaminated surgical 
ield which increases the chances of contamination. In 
addition, transvaginal repairs are essentially mesh ‘onlay’ 
procedures, particularly anterior and posterior colporraphy 
procedures, which make them prone to colonization by 
vaginal microbial lora, as they lie very close to the skin 
[18].
The transvaginal mesh tape insertions for SUI are slightly 
diferent than other transvaginal mesh insertions, because 
in these operations, a smaller surface area of the mesh lies 
in close proximation to the vaginal skin, but maybe more 
importantly, the theoretical basis for use of the mesh for SUI 
is better studied with better deined targets for surgical treat-
ment. For example, placement of a synthetic tape underneath 
the mid urethra was conceptualized with the introduction of 
mid-urethral sling surgeries with demonstration of pre- and 
post-operative urethral pressures.
Hence, although the transvaginal route has been the most 
commonly used route for POP repair, the safety of mesh aug-
mented transvaginal POP repair procedures is now widely 
questioned with a mesh erosion rate of 8% in 1–3 year fol-
low-up and which can go up to 42% in longer term follow-
up [19]. There appears to be a consensus on lack of safety 
with transvaginal mesh implantation for POP. In contrast, 
currently, tension-free vaginal tape procedures for SUI have 
long-term subjective cure rates of up to 93% [20] with mesh-
related complications occurring in 4% of patients [21]. Cur-
rent expert opinion suggests that the beneits of these opera-
tions still outweigh the risks with a high level of evidence.
With regard to infectious complications of transvaginal 
mesh surgeries, the most recent PROSPECT trial [22] dem-
onstrated that the rate of infectious complications with the 
vaginal mesh was less than 1% [22], although higher rates 
have been reported of up to 8% [9]. However, in a series of 
mesh explantation surgeries after treatment of SUI and POP, 
mesh exposure without signs of infection was responsible 
for 44 of 83 cases, with 30 of 84 meshes excised due to 
infection [23].
Tissue reactions to the surgical mesh 
and the scientiic evidence for mesh infection
Occurrence of vaginal mesh-related complications, as we 
see in the daily clinical practice, are probably multifactorial 
including the inherent complexity of pelvic loor disorders 
that are still not incompletely understood [24], the material 
and biomechanical properties of the mesh being unsuitable 
for use in pelvic loor, limitations pertinent to the surgical 
techniques used, and failure of regulatory processes for 
approval and surveillance of implantable medical devices.
Infectious complications of the vaginal mesh can be 
thought of as a clinical entity with speciic signs and posi-
tive culture results, but also it can be a subclinical infection 
afecting the normal host response to the mesh and its’ tis-
sue integration. Alternatively, we can observe complications 
associated with an inlammatory reaction to the mesh mate-
rial with a completely sterile mesh without infection. In this 
section, we will review the available evidence on the host 
tissue response to the PPL mesh and how this could relate 
to clinical outcomes.
Host response to PPL mesh
Surgical mesh became available as a material after the plas-
tics revolution and started to be used in hernia repair [4]. 
Plastic materials provided signiicant advantages over the 
metal prosthesis, the only available alternative then used 
in soft-tissue reconstruction because of their better ductil-
ity and strength. Plastics, however, came with a new set of 
material properties that was initially problematic when used 
with traditional material design strategies and available sur-
gical techniques of implantation. Some of these properties 
needed to be optimised over the years to obtain the best 
treatment outcomes [5]. These improvements were made in 
the context of hernia surgeries over 50 years before mesh 
was used in pelvic loor repair.
The biocompatibility of the mesh is mainly determined 
by its textile properties, namely, the porosity and the pore 
size. Lighter weight meshes with large pores are known 
to integrate better into host tissues with less foreign body 
reaction, ibrosis, and the associated pain sensation [25, 
26]. Clinical studies comparing heavy and light-weight PPL 
mesh materials implanted for inguinal hernia repairs dem-
onstrated less pain and less sensation of a foreign material 
with lighter meshes [27]. However, lighter weight meshes 
are more lexible which caused efective loss of pores after 
mechanical loading in vivo and this led to some issues for 
the deinition of pore size and pore stability [28]. Prolapse 
meshes are thought to be more likely to lose their pores after 
implantation in vivo compared to hernia meshes Auxetic 
materials have been developed for use in prolapse repair 
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[29]; however, their eicacy in reducing mesh-related com-
plications is yet to be explored.
It has also been demonstrated repeatedly that the type of 
the mesh material afects its biocompatibility. Meshes made 
of polyester or polytetraluoroethylene (PTFE) are known 
to be more susceptible to bacterial colonization, and eforts 
have been focused on the improvement of their antibacterial 
properties. For example, PTFE has been modiied to release 
two antimicrobial molecules (silver salts and chlorhexidine) 
used in vaginal implantations in a small series [30]. How-
ever, it is widely accepted today that implantations through 
the vaginal route increase the risk of contamination and that 
the best material is monoilament macroporous PPL for this 
application [31].
In case of the PPL mesh, the host response has tradition-
ally been studied for applications in abdominal hernia repair 
with recent evidence focused on vaginal implantations. The 
PPL mesh is known to trigger an inlammatory response 
characterized by polarization of macrophages towards an M1 
phenotype, as opposed to M2. An M1 phenotype leads to a 
pro-inlammatory response, while an M2 results in a con-
structive remodelling response [32]. In addition, the M1/M2 
ratio has been shown to be less favourable with increased 
molecular weight PP mesh and with smaller pore sizes, sug-
gesting that the mesh burden (the amount of mesh in contact 
with tissues) is a factor inluencing its biocompatibility [33].
Biocompatibility is deined for each speciic application 
of a biomaterial as its ability to perform with an appropriate 
host response [34]. The biocompatibility of the PPL mesh 
for applications in the pelvic loor started to being deined 
after 2007 in the sheep [35]. The sheep have a vagina that 
is similar in size to the human vagina allowing larger pieces 
of the mesh to be implanted and they can spontaneously 
develop POP. A site-speciic host response to PPL mesh in 
sheep models has demonstrated mesh-related complications 
(exposure and contraction) to occur signiicantly more in 
transvaginal mesh implantations as compared to abdomi-
nal implantations, where the same materials caused less 
than 10% contraction and no erosion [36]. Later on, clini-
cal data from women who underwent vaginal mesh excision 
due to complications revealed an M1 (pro-inlammatory) 
macrophage response even years after the implantation of 
mesh, with a higher expression of proteolytic enzymes in 
explants of women who had mesh exposure compared to 
women with pain [37].
PPL‑related infection
The events in the tissue–material interface leading to 
device-related infections are well studied. Initially, the 
microorganisms attach and adhere to the surface of the 
material via physicochemical interactions including Van 
der Waals forces, hydrophobic, and electrical interactions. 
Microorganisms can also attach on to the proteins adsorbed 
on the surface of the material. After attachment, microorgan-
isms proliferate and form multi-layered clusters via speciic 
intercellular adhesion polysaccharides [38]. The presence of 
such accumulated bioilms has been demonstrated on several 
implanted devices including these surgical meshes [39].
The presence of a mesh-related infection can modify 
the host tissue response to the implanted material [40]. 
As soon as a biomaterial is implanted, a ‘race to surface’ 
begins between the host cells and the microorganisms. A 
biomaterial-associated infection will afect the integration of 
the implant into the host. Although it is easy to distinguish 
between an implant which is clinically infected and a suc-
cessfully integrated implant, it is not so easy to detect low 
levels of infection in an implant. Furthermore, this situation 
is a dynamic process that can change over years.
Bacteria generally form bioilms on the surface of bio-
medical implants. Bioilms are aggregates of bacteria with 
a surrounding extracellular matrix (extracellular polymeric 
substances) that is tightly attached to the biomaterial surface. 
Bacteria in bioilms are resistant to antimicrobial therapies 
and they can easily evade the host immune responses giving 
rise to a state of chronic inlammation [41]. The relationship 
between microbial bioilms and capsular contraction with 
breast implants has been extensively studied in pre-clinical 
and clinical studies, which is reviewed elsewhere [42]. It 
appears that bioilm formation is an acknowledged factor 
increasing the occurrence of capsular contraction. Although 
the mechanisms underlying mesh contraction by the host tis-
sues are not clear, it can be argued that bacterial colonization 
of the vaginal mesh can afect the host response against the 
mesh and can contribute to mesh contraction in the absence 
of obvious signs of infection.
At the time of writing, there have not been enough studies 
reported to support or refute this hypothesis. Histological 
analysis of 100-explanted meshes revealed a periprosthetic 
tissue reaction identical to that of a periprosthetic abscess, 
regardless of an infectious cause of mesh explantation, and/
or a chronic inlammation rich in giant cells and mononu-
clear cells [43]. However, experimental studies in rats have 
demonstrated that both absorbable and non-absorbable 
meshes shrink more when they are infected [44].
In conclusion, for any given synthetic implant, there will 
be a host response. The ideal situation is that the biomaterial 
and the host tissues can ind a state of mutually acceptable 
co-existence.
The relationship between surgical technique and infection
SUI and POP commonly occur together due to challenges 
which the female pelvic loor must cope with. A combina-
tion of genetic and acquired factors that are most probably 
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aggravated by childbirth lead to the occurrence of SUI and 
POP. Although the exact mechanisms by which an interac-
tion of these factors results in pelvic loor disorders are not 
completely elucidated, the clinical picture involves initial 
mechanical damage to the pelvic loor that generally fol-
lows birth trauma, previous pelvic surgeries, menopause, 
and increasing age. Current surgical treatments for SUI 
and POP are based on restoration of normal anatomy in the 
female pelvic loor either augmented by mesh or not.
PPL mesh was irst designed for use in the treatment of 
abdominal hernia. For its use in this application, the mate-
rial properties of the mesh and the surgical technique of 
implantation developed hand by hand over years to obtain 
best outcomes for hernia repairs. For example, in incisional 
hernia repair, onlay mesh repairs were replaced with sublay 
repairs, where the mesh is placed underneath a thick muscle 
tissue (retro-rectus) in a well-vascularized wound bed and 
away from the skin. Onlay mesh repairs required a large area 
of the mesh to stay in very close proximity to skin increasing 
the chances of mesh colonization and infection [45].
When adopting the mesh for vaginal mesh implantations, 
the design requirements for speciic application in the pelvic 
loor were not considered. In vaginal mesh implantations, the 
mesh stays in very close proximation to the vaginal mucosa, 
as there are no natural tissue planes in this region such as 
subcutaneous or muscle tissue layers, unlike in abdominal 
implantations, where the mesh material is implanted in-
between clearly identiiable fat, muscle, and fascia tissue 
planes.
Furthermore, there are other observations supporting the 
argument that an inlammatory reaction to the mesh or a 
subclinical infection caused by the introduction of the mesh 
may contribute to the occurrence of mesh-related compli-
cations. It has been repeatedly demonstrated that vaginal 
mesh complications are known to increase with increasing 
amounts of mesh used [36, 46]. In addition, clinical studies 
showed that avoiding an overlapping suture line during mesh 
implantation reduces mesh exposure [47, 48]. In addition, 
mesh exposure mostly occurs in the midline, suggesting a 
poor wound healing afected by the presence of the mesh 
[49]. Taken all together, this implies that mesh erosion can 
be followed from an abnormal wound healing of the incised 
vaginal mucosa due to a poorly vascularized wound bed 
combined with the surgical intervention and the presence 
of large amount of mesh material.
Pathogens detected in infected vaginal mesh
For abdominal hernia meshes, Staphylococcus aureus (S 
aureus) is the most commonly isolated organism (more 
than 80% of cases) followed by E. coli, Enterococcus, and 
Candida [50]. Of the isolated S aureus, most were methicil-
lin-resistant S aureus. Microbiologic analysis of explanted 
vaginal meshes demonstrated multi-microbial cultures in the 
majority of the cases (31%), and when solitary bacteria grew, 
coagulase-negative Staphylococci, E. coli, Proteus mirabilis, 
and Streptococcus agalactiae were detected, the quantity of 
which mostly is less than  103/mL [51]. In an analysis of 
175 excised mesh specimens, 77% of cultures were positive 
with 37% being positive for at least one pathogenic bacteria. 
Staphylococcus was the most commonly isolated organism 
followed by Enterococcus and Finegoldia magna [10].
Methods to prevent infectious complications 
after vaginal mesh implantation
For any implantable or indwelling medical device, infec-
tion in the acute or chronic setting is an issue. When an 
infection related to a medical device occurs, the clini-
cian needs to make a judgement whether to salvage the 
implanted device or to remove the infected device. This 
clinical decision will need to take into account several 
key factors including the importance of the device to the 
patients’ survival/wellbeing and the ease of removal/rep-
licability of the device, eicacy of the antibiotic therapy 
used, and the factors related to patients’ clinical situation 
such as existence of immunosuppression or sepsis. Often, 
the removal of the device is required, because an antibi-
otic/antimicrobial therapy alone is generally not suicient 
to clear the infection due to bioilm formation.
Strategies to prevent mesh-related infections start with 
recognition of factors that increase the likelihood of vagi-
nal mesh infections. Several pre-operative patient-related 
risk factors have been suggested to inluence the mesh-
related complications including smoking, age, obesity, dia-
betes, immunocompromised status, and vaginal atrophy. 
Although speciic risk factors that increase mesh infection 
have not been identiied, smoking and obesity are risk fac-
tors for vaginal mesh exposure [31]. This issue has been 
studied more for the abdominal hernia repair procedures, 
suggesting that patient-related factors such as smoking, 
uncontrolled diabetes, obesity, and previous hernia repair 
can increase the risk of infectious complications with 
mesh. In addition, risk prediction tools are available for 
use with individual patients undergoing abdominal hernia 
repair [50]. Therefore, optimization of pre-operative risk 
factors can be a irst step in prevention of infections.
Specific guidance is not available on pre-operative 
measures to reduce mesh infections. Standard infection 
control measures including hand hygiene, cutaneous 
asepsis, and prophylactic antibiotics can be considered. 
The only available guidance has been published by the 
French college of Obstetrics and Gynecology on preven-
tion of complications related to use of prosthetic meshes 
in prolapse surgery [31]. Use of antibiotic prophylaxis, 
cleaning with an antiseptic foam solution followed by 
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disinfection of the surgical site, use of double gloves and 
change of gloves at each stage of the operation, remov-
ing the package of the mesh at the very last moment, and 
manipulation of the mesh with a clean pair of gloves are 
all recommended. In addition, minimizing the surface area 
of the implanted mesh, good haemostasis before closure, 
and intermittent irrigation of the hernia sac/implant wound 
bed with antibiotic solution have also been described for 
hernia cases; however, the relevance of these on vaginal 
mesh procedures is not known.
Novel approaches in materials’ design to reduce 
mesh‑related infections
Material properties of the surgical mesh can be modiied to 
make it more resistant to colonization with bacteria. Sur-
face modiication and antimicrobial functionalisation of the 
biomedical implants have been the most frequently studied 
strategies. In the context of hernia meshes, soaking the mesh 
in an antimicrobial solution and coating the mesh with drug 
releasing polymers or antimicrobial metals such as silver 
nanoparticles have been studied.
In pelvic loor meshes, coating the PPL mesh with silver 
nanoparticles was found to decrease bacterial attachment 
in vivo [52]. Because the nondegradable meshes are not 
good drug releasing polymers, and only soaking strategies 
fail to achieve a sustained release state, coating the mesh 
with other polymers such as polylactic acid has been used 
as a strategy for carrying the antimicrobials [53]. Since there 
are limitations of this drug releasing approaches to achieve 
long-term release of the antimicrobials, other ways of incor-
porating agents into the mesh material have also been stud-
ied. Chemical modiication of polymer surfaces to bind anti-
microbial agents has also been studied experimentally [54].
Recent issues on the use of vaginal PPL mesh and the 
search for alternative materials have led to emergence of 
degradable or non-degradable electrospun materials as alter-
natives [55, 56]. In animal experiments, these materials have 
been repeatedly demonstrated to be iniltrated by host tissues 
soon after implantation and the host response to these mate-
rials has been characterized as driven by an M2 (remodel-
ling) response [57]. A commonly cited concerns about these 
materials are their pore sizes in relation with their ability to 
accommodate host tissue cells before the pores invaded by 
the microorganisms.
The mechanisms underlying microbial attachment to elec-
trospun surfaces are not extensively studied. The attachment 
of bacteria to the ibres of the electrospun materials is prob-
ably diferent than those on the lat surfaces that are rela-
tively better described [58]. The nanotopography, chemistry, 
and roughness of the micro/nanoibres of the electropsun 
matrices can theoretically afect the attachment of bacte-
ria. It was demonstrated that the ibre diameter inluenced 
attachment of bacteria to the ibre, with smaller diameters 
decreasing attachment in polystyrene electrospun mesh [59]. 
Fibre diameter also inluences the ability of the bacteria to 
proliferate and colonize the scafold.
The attachment of cells to electropun ibres is known to 
be afected by the ultrastructural arrangement of the ibres 
within the electrospun mesh such as inter-ibre distance 
(pore size) and ibre alignment [60]. The attachment of bac-
teria on to these surfaces can also be expected to be inlu-
enced by the same ultrastructural properties. Furthermore, 
functionalization of the electrospun scafolds with drugs or 
surface modiications can have efects on bacterial attach-
ment that needs to be considered. Ideally, these surfaces 
would be designed, so that they facilitate attachment of host 
cells while inhibiting bacterial attachment, proliferation, and 
bioilm formation.
Conclusion
In summary, at the time of writing, PPL mesh implants are 
known to cause an unfavourable host response with persis-
tent inlammation leading to the clinical observed mesh-
related complications. Some clinical and scientiic evidence 
suggests that a subclinical infection due to a contaminated 
mesh can contribute to a sustained inflammation at the 
mesh-tissue interface leading to a poor tissue integration; 
nevertheless, to verify this, more research is required to 
identify the speciic underlying mechanisms. Finally, meth-
ods to prevent infection are described.
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